Antibiotic duration is often longer than necessary. Understanding the reasons for variability in antibiotic duration can inform interventions to reduce prolonged antibiotic use. Fernandez-Lazaro, et al. (2019) sought to describe patterns of inter-physician variability in prescribed antibiotic treatment durations and determine physician predictors of prolonged antibiotic duration in the community setting.
The researchers performed a retrospective cohort analysis of family physicians in Ontario, Canada, between March 1, 2016 and Feb. 28, 2017, using the Xponent TM dataset from IQVIA. The primary outcome was proportion of prolonged antibiotic course prescribed, defined as > 8 days of therapy. We used multivariable logistic regression models, with generalized estimating equations to account for physician level clustering to evaluate for predictors of prolonged antibiotic courses.
There were 10,616 family physicians included in the study, prescribing a total of 5.6 million antibiotic courses. There was substantial inter-physician variability in the proportion of prolonged antibiotic courses (median 33.3%, interquartile range 21.9â47.2%, interdecile range 13.5â60.3%). In the multivariable regression model, later physician career stage, rural location, and a larger pediatric practice were significantly associated with greater use of prolonged courses. Prolonged courses were more likely to be prescribed by late-career physicians (adjusted odds ratio 1.48, 95% confidence interval 1.38â1.58) and mid-career physicians (1.25, 1.16â1.34) when compared to early-career physicians.
The researchers observed substantial variability in prescribed antibiotic duration across family physicians, with durations particularly long among late-career physicians. They say these findings highlight opportunities for community antimicrobial stewardship interventions to improve antibiotic use through addressing practice differences in later career stage physicians.
Reference: Fernandez-Lazaro CI, et al. Late-Career Physicians Prescribe Longer Courses of Antibiotics. Clinical Infectious Diseases. Jan. 7, 2019. https://doi.org/10.1093/cid/ciy1130
Source: Clinical Infectious Diseases
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.